NHS chief executive, Sir Simon Stevens, has announced plans for a £160m initiative to roll-out ‘COVID-friendly’ cancer treatments for patients across the UK. The money will be used to pay for treatments, which do not have as big an impact on patients’ immune systems but require less hospital visits compared to other drugs. Thereby meaning
Vertex has achieved an agreement with NHS England to reimburse its triple combination therapy Kaftrio (ivacaftor/tezacaftor/elexacaftor) in combination with Kalydeco (ivacaftor), should the medicine win European approval. The new expanded agreement includes reimbursed access to Vertex’ currently licensed medicines – Kalydeco (ivacaftor), Orkambi (lumacaftor/ivacaftor) and Symkevi (tezacaftor/ivacaftor), as well as the triple combination therapy if
NHS England has confirmed four new integrated care systems (ICS) in England, joining the 14 already in existence plus two devolved health systems in Greater Manchester and Surrey. The action leads to around half of England’s population now being served by such a system, including the whole of Yorkshire (with the confirmation of an ICS
The NHS Confederation and other UK health leaders have urged the incoming Government to “address the critical issues that will improve and transform services for patients.” As a result of a recent survey conducted prior to the incoming election, the organisations warned that a lack of staffing and failure to address the pensions crisis is
The NHS in England is setting up a national artificial intelligence (AI) laboratory to enhance care of patients and research. Health Secretary, Matt Hancock, said AI had “enormous power” to improve care, save lives and ensure doctors had more time to spend with patients. He has announced that £250m will be spent on boosting the
NHS England has announced that its Time for Care programme has freed up more than half a million hours of time for patients in the last year. The innovative programme involved surgeries across the country to adopt new ways of working like letting patients book appointments sooner, cutting paperwork and offering faster access to different
NHS England is now targeting Australia in order to increase GP numbers. The group aims to target GPs who left the UK for Australia and are looking to return home, as well as GPs from Australia who want the opportunity to work in their field in Britain. The international recruitment drive, which is designed to
An innovative cancer immunotherapy has been initially rejected as a treatment for some adults with an aggressive type of non-Hodgkin lymphoma on the NHS in England. Although the decision will be reviewed by NICE at the end of October. Tisagenlecleucel (Kymriah) is part of a new line of immune-boosting treatments called CAR T cell therapies,
The government has recently announced an investment of £215 million with the aim of funding NHS health research to “transform the lives” of millions of people in the UK that are living with a range of conditions. Academics and technology experts will be able to apply for funding to develop new health solutions that provide
The UK Space Agency will invest up to £4 million into finding hi-tech solutions to major health and care challenges that the NHS is facing in its 70th anniversary year, under a joint initiative with NHS England. Approximately four applications will receive cash from the Agency to transform technology originally designed for use in space
